What do we know about the function of SARS-CoV-2 proteins?

被引:2
|
作者
Arevalo, Santiago Justo [1 ,2 ]
Castillo-Chavez, Adriana [1 ]
Calampa, Carmen Sofia Uribe [1 ]
Sifuentes, Daniela Zapata [1 ,2 ]
Huallpa, Cesar J. [3 ]
Bianchi, Gianfranco Landa [1 ]
Casas, Romina Garavito-Salini [1 ]
Aguilar, Mauro Quinones [1 ]
Chavarria, Roberto Pineda [1 ]
机构
[1] Univ Ricardo Palma, Fac Ciencias Biol, Lima, Peru
[2] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil
[3] Univ Nacl Agr La Molina, Fac Ciencias, Lima, Peru
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
巴西圣保罗研究基金会;
关键词
immune pathways; COVID-19; pandemic; translation inhibition; viral infection; SARS-CORONAVIRUS; STRUCTURAL BASIS; INHIBITORS; REPLICATION; REVEALS; BRAIN; NSP3;
D O I
10.3389/fimmu.2023.1249607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The COVID-19 pandemic has highlighted the importance in the understanding of the biology of SARS-CoV-2. After more than two years since the first report of COVID-19, it remains crucial to continue studying how SARS-CoV-2 proteins interact with the host metabolism to cause COVID-19. In this review, we summarize the findings regarding the functions of the 16 non-structural, 6 accessory and 4 structural SARS-CoV-2 proteins. We place less emphasis on the spike protein, which has been the subject of several recent reviews. Furthermore, comprehensive reviews about COVID-19 therapeutic have been also published. Therefore, we do not delve into details on these topics; instead we direct the readers to those other reviews. To avoid confusions with what we know about proteins from other coronaviruses, we exclusively report findings that have been experimentally confirmed in SARS-CoV-2. We have identified host mechanisms that appear to be the primary targets of SARS-CoV-2 proteins, including gene expression and immune response pathways such as ribosome translation, JAK/STAT, RIG-1/MDA5 and NF-k beta pathways. Additionally, we emphasize the multiple functions exhibited by SARS-CoV-2 proteins, along with the limited information available for some of these proteins. Our aim with this review is to assist researchers and contribute to the ongoing comprehension of SARS-CoV-2's pathogenesis.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] SARS-CoV-2; What We Know so far
    Rajani, Huda Fatima
    Alshaikh, Fatima Ahmed
    Anushiravani, Amir
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (07) : 498 - 502
  • [22] What Do We Know So Far About Gastrointestinal and Liver Injuries Induced by SARS-CoV-2 Virus?
    Cao, Weibiao
    [J]. GASTROENTEROLOGY RESEARCH, 2020, 13 (06) : 225 - 226
  • [23] Immune Profiling of SARS-CoV-2; What We Know and What We Don't Know
    Zohouri, Mahshid
    Ghods, Atri
    Zamir, Mina Roshan
    Shokri, Fazel
    Ghaderi, Abbas
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2023, 22 (03) : 217 - 232
  • [24] Indirect transmission of severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2): What do we know and what do we not know?
    Ijaz, M. Khalid
    Nims, Raymond W.
    McKinney, Julie
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (05): : 676 - 678
  • [25] What we have to know about corticosteroids use during Sars-Cov-2 infection
    F. Ferraù
    F. Ceccato
    S. Cannavò
    C. Scaroni
    [J]. Journal of Endocrinological Investigation, 2021, 44 : 693 - 701
  • [26] What we have to know about corticosteroids use during Sars-Cov-2 infection
    Ferrau, F.
    Ceccato, F.
    Cannavo, S.
    Scaroni, C.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (04) : 693 - 701
  • [27] SARS-CoV-2 transmission through human body donors: What do we know?
    Leake, Michael
    Bazan, Jose A.
    Balta, Joy Y.
    [J]. JOURNAL OF ANATOMY, 2022, 240 (04) : 806 - 806
  • [28] Lipschutz Ulcer and SARS-CoV-2: What We Currently Know?
    Merlino, Lucia
    Volpicelli, Agnese Immacolata
    Dominoni, Mattia
    Pasquali, Marianna Francesca
    D'Ovidio, Giulia
    Gardella, Barbara
    Senatori, Roberto
    Battino, Maurizio
    [J]. DISEASES, 2023, 11 (03)
  • [29] The SARS-CoV-2, tears, and ocular surface debate: What we know and what we need to know
    Ali, Mohammad Javed
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (07) : 1245 - 1246
  • [30] Infodemic and misinformation. What do we know about the effectiveness and the efficacy of the vaccine against / for SARS-CoV-2 / COVID?
    De Vito, Eduardo L.
    Catalano, Hugo N.
    [J]. MEDICINA-BUENOS AIRES, 2020, 80 : 107 - 109